Ads
related to: bcrx stock forecast
Search results
Analysts Are Updating Their BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Estimates After Its...
Simply Wall St. via Yahoo Finance· 3 days agoNasdaqGS:BCRX Earnings and Revenue Growth May 9th 2024 Taking into account the latest results, the...
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 5 days agoBioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q1 2024 Earnings Call Transcript May 6, 2024 BioCryst...
BioCryst Pharmaceuticals, Freshpet rise; Luminar, Integra fall, Tuesday, 5/6/2024
Seattle Times· 6 days agoStocks that are trading heavily or have substantial price changes on Monday: BioCryst Pharmaceuticals, Freshpet rise; Luminar, Integra fall.
HC Wainwright Reiterates “Buy” Rating for BioCryst Pharmaceuticals (NASDAQ:BCRX)
ETF DAILY NEWS· 3 days agoBioCryst Pharmaceuticals (NASDAQ:BCRX – Get Free Report)‘s stock had its “buy” rating reiterated by equities researchers at HC Wainwright in a research ...
BioCryst: Q1 Earnings Snapshot
Associated Press Finance via Yahoo Finance· 6 days ago(AP) — BioCryst Pharmaceuticals Inc. (BCRX) on Monday reported a loss of $35.4 million in its first quarter. The Durham...The drugmaker posted revenue of $92.8 million in ...
BioCryst Pharmaceuticals 'Fantastic' Q1 Earnings Rides On Outstanding Orladeyo Performance
Benzinga via AOL· 5 days agoMonday, BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) reported a first-quarter earnings loss of $(0.17)...
Earnings call: BioCryst exceeds Q1 expectations, raises ORLADEYO guidance By Investing.com
Investing.com· 5 days agoBioCryst (NASDAQ:BCRX) Pharmaceuticals, Inc. (NASDAQ: BCRX) has reported a strong first quarter in...
BioCryst Pharmaceuticals Reports Strong Q1 2024 Results, Exceeding Analyst Revenue Forecasts
GuruFocus.com via Yahoo Finance· 6 days agoThe company also anticipates achieving full-year operating profit in 2024, excluding non-cash stock...
